Nylim US LG Ca R&D LD ETF-UiLRNDETF

13F holders, Q3 2025 (September 30)
2holders −3
0new positions
3sold out
$39.79avg. 13F price*

At the end of Q3 2025, 2 institutions reported holding Nylim US LG Ca R&D LD ETF-Ui (LRND) in their 13F filings, down 3 from Q2 2025. 0 opened new positions and 3 sold out. The largest holders were New York Life Investment Management LLC ($7.6M) and GTS Securities LLC ($521K).

Company
Nylim US LG Ca R&D LD ETF-Ui
Filed as
NEW YORK LIFE INVESTMENTS ET (Q3 2025)
CUSIP
45409B263
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246 Q1 2024: 3Q1 2024Q2 2024: 2Q2 2024Q3 2024: 3Q3 2024Q4 2024: 3Q4 2024Q1 2025: 4Q1 2025Q2 2025: 5Q2 2025Q3 2025: 2Q3 2025Q4 2025: 5Q4 2025Q1 2026: 5Q1 2026Q2 2026: 6Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits3$5K

All 13F filers, Q2 2025 → Q3 2025: 3,462 shares sold, net −3,462 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

New York Life Investment Management LLC 0.07% No change 190,000 $7.6M
GTS Securities LLC 0.02% Reduce -20.3% 13,087 $521K

"% of holder's portfolio" is LRND's weight in each manager's 13F, not the share of Nylim US LG Ca R&D LD ETF-Ui the manager owns.